Latest Shire Stories
PHILADELPHIA and LEXINGTON, Mass., June 21, 2011 /PRNewswire/ -- A new international awards program intended to recognize everyday people who serve as caregivers has been launched by Shire Pharmaceuticals, the global specialty biopharmaceutical company.
SEATTLE, May 25, 2011 /PRNewswire/ -- Students with ADHD struggle with the difficult transition from high school to higher education. Studies indicate that between 50 to 95 percent(1) of college students with ADHD drop out.
DUBLIN, May 25, 2011 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that its subsidiary Shire LLC has received Paragraph IV Notice Letters from Amneal Pharmaceuticals, LLC.
DUBLIN, April 26, 2011 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company (the "Company") announces that at its Annual General Meeting today, all resolutions contained in the notice of meeting were duly passed and the results of the poll are as follows: For* Against Withheld** 1.
- Withering but not falling off, as a blossom that persists on a twig after flowering.